Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
NCT ID: NCT01987882
Last Updated: 2021-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2014-06-30
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Outcomes of Hip Interventions for Children With Cerebral Palsy
NCT04792606
Hip Reconstruction in Cerebral Palsy With Pelvic Osteotomy
NCT02372617
Cerebral Palsy Hip Health Related Quality of Life
NCT01773161
Targeted Hip Strength Training in Children With Cerebral Palsy (CP)
NCT01633736
A Randomized Control Trial of Hip Dislocation Techniques for Pediatric Patients With Cerebral Palsy
NCT02259140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design \& Participants: International multi-centre prospective longitudinal cohort study of children with severe (non-ambulant) cerebral palsy (GMFCS levels IV \& V) from ages 3 to 18 who have radiographic evidence of hip displacement \[Reimer's Migration Percentage (MP) ≥ 30%\].
Measures: Detailed demographic information, and prognostic factors, including co-morbid conditions will be recorded at baseline, in addition to self-administered parental reports of HRQL as measured by the CPCHILD. Hip status will be classified using standardized radiographic measures of Reimer's MP and acetabular index (AI). The primary outcome measure CPCHILD, as well as the MP \& AI will be measured at 6, 12 and 24 months following initial intervention.
Aim 1: Measure the impact of increasing hip displacement in children with severe (non-ambulant) CP on their HRQL as measured by the CPCHILD questionnaire.
Aim 2: (Primary Purpose): Measure the effectiveness of different strategies of interventions for hip displacement in children with severe (non-ambulant) CP in a prospective longitudinal comparative cohort study using the CPCHILD as the primary outcome measure of HRQL.
Aim 3: Compare the types and rates of adverse events and complications associated with each of the treatment cohorts.
Methods: Observational study of usual (site/surgeon specific) clinical practice. Investigators at each site will enroll eligible participants and assign each to one of the following 5 cohorts based on individual treating doctor's \&/or parental preferences:
A. "Natural" history or watchful waiting (N=100)
B. Serial botulinum toxin injections +/- abduction bracing (N=100)
C. Adductor (+/- psoas) muscle releases alone (N=100)
D. Hip reconstructive surgery (N=100)
E. Salvage hip surgery (N=100)
The baseline MP and CPCHILD scores for all participants will be analyzed cross-sectionally to evaluate the correlation between hip displacement and the CPCHILD scores to serve Aim 1. For Aim 2, children undergoing interventions for hip instability (Groups B, C, D, \& E) will be compared with each other as well as with their respective matched counterparts of untreated children (Group A), using repeated measures of analysis of covariance (ANOCOVA) to measure the mean change in scores from baseline at 6, 12 and 24 months after intervention.
Timelines: 500 participants will be recruited in 24 months, and followed for 24 months. The analysis, reporting of results, manuscript development and knowledge transfer will take 12 months. In total, the study will take 5 years to complete.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A. "Natural" History or Watchful Waiting
No interventions assigned to this group
B. Serial Botulinum Toxin Injections +/- Abduction Bracing
No interventions assigned to this group
C. Adductor (+/- psoas) Muscle Releases Alone
No interventions assigned to this group
D. Hip Reconstructive Surgery
No interventions assigned to this group
E. Salvage Hip Surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 2 to 18 years of age
* Has a migration percentage ≥ 30%
* Non-ambulatory; the primary mode of mobility is a wheelchair
* Parent/primary caregiver must understand one of the languages in which the CPCHILD has been translated, culturally adapted and validated.
Exclusion Criteria
* Received botulinum toxin injection within the previous 3 months. Recruitment will be delayed until at least 3 months after prior botulinum toxin injection.
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hospital for Sick Children
OTHER
Holland Bloorview Kids Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Unni Narayanan, MBBS, MSc, FRCSC
Role: PRINCIPAL_INVESTIGATOR
Holland Bloorview Kids Rehab and The Hospital for Sick Children, Toronto, Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shriners Hospitals for Children - Northern California
Sacramento, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Alfred I. Dupont Institute
Wilmington, Delaware, United States
Children's Hospital Boston
Boston, Massachusetts, United States
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, United States
Children's of Mississippi
Jackson, Mississippi, United States
Hospital for Special Surgery
New York, New York, United States
New York-Presbyterian Morgan Stanley Children's Hospital
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Royal Children's Hospital
Melbourne, Victoria, Australia
BC Children's Hospital
Vancouver, British Columbia, Canada
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Shriners Hospital for Children - Canada
Montreal, Quebec, Canada
Aarhus University Hospital
Aarhus, , Denmark
Safra Hospital for Children
Tel Litwinsky, Ramat Gan, Israel
Starship Children's Hospital of New Zealand
Auckland, , New Zealand
K. Marcinkowski Medical University
Poznan, , Poland
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Lund University Hospital
Lund, , Sweden
Astrid Lindgren's Children's Hospital
Stockholm, , Sweden
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, England, United Kingdom
Alder Hey Children's NHS Foundation Trust
Liverpool, England, United Kingdom
Royal National Orthopaedic Hospital
London, England, United Kingdom
The Royal London and St. Bartholomew's Hospitals
London, England, United Kingdom
Nuffield Orthopaedic Centre NHS Trust
Oxford, England, United Kingdom
Royal Hospital for Sick Children
Edinburgh, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12. doi: 10.1017/S0012162206001745.
Miller SD, Juricic M, Fajardo N, So J, Shore BJ, Narayanan UG, Mulpuri K. Variability in Postoperative Immobilization and Rehabilitation Following Reconstructive Hip Surgery in Nonambulatory Children With Cerebral Palsy. J Pediatr Orthop. 2021 Aug 1;41(7):e563-e569. doi: 10.1097/BPO.0000000000001850.
Related Links
Access external resources that provide additional context or updates about the study.
Website of the CPCHILD© Project
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
313575
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.